| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 12, 2025 | Merus N.V. | CEO | Sell | 36.3 | -83,435 | -100.00% | ✗ | $8.1M |
| Nov 3, 2022 | Nov 3, 2022 | Merus N.V. | CEO | Buy | 95.0 | +14,706 | 23.21% | ✓ | $211.4K |
| Aug 22, 2022 | Aug 23, 2022 | Merus N.V. | CEO | Buy | 95.0 | +5,826 | 29.07% | ✓ | $133.6K |
| Aug 19, 2022 | Aug 22, 2022 | Merus N.V. | CEO | Buy | 83.8 | +704 | 3.64% | ✓ | $16.2K |
| Jul 12, 2022 | Jul 13, 2022 | Merus N.V. | CEO | Buy | 95.0 | +4,340 | 28.93% | ✓ | $99.7K |
| Oct 24, 2016 | Feb 10, 2017 | CRISPR Therapeutics AG | Chief Scientific Officer | Buy | 55.0 | +400 | 0.08% | ✗ | $5.6K |